Oncology
Outcomes Research in Review
Oral Relugolix Yields Superior Testosterone Suppression and Decreased Cardiovascular Events Compared With GnRH Agonist
FDA/CDC
FDA okays new CAR T therapy, first for mantle cell lymphoma
FDA/CDC
FDA approves oral therapy for myelodysplastic syndromes, CMML
Under a priority review, the FDA approved a combination tablet for treatment of people with myelodysplastic syndromes or chronic myelomonocytic...
News
FDA approves in-home breast cancer treatment
Conference Coverage
Combo drug improves survival in older patients with high-risk/secondary AML
News
More than 10,000 excess cancer deaths because of COVID-19 delays
Article
Can an app guide cancer treatment decisions during the pandemic?
Article
‘A good and peaceful death’: Cancer hospice during the pandemic
News
Acute lymphoblastic leukemia can be successfully treated in the frail elderly
Attenuated chemotherapy shows effectiveness in frail and elderly ALL patients.
News
FDA approves mAb combo for hepatocellular carcinoma
Approval was based on results from the phase 3 IMbrave150 trial.